Redwine Jeffrey M, Kosofsky Barry, Jacobs Russell E, Games Dora, Reilly John F, Morrison John H, Young Warren G, Bloom Floyd E
Neurome, Incorporated, La Jolla, CA 92037, USA.
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1381-6. doi: 10.1073/pnas.242746599. Epub 2003 Jan 24.
High-resolution magnetic resonance microscopy (MRM) was used to determine regional brain volumetric changes in a mouse model of Alzheimer's disease. These transgenic (Tg) mice overexpress human mutant amyloid precursor protein (APP) V717F under control of platelet-derived growth factor promoter (PDAPP mice), and cortical and hippocampal beta-amyloid (Abeta) deposits accumulate in heterozygotes after 8-10 mos. We used MRM to obtain 3D volumetric data on mouse brains imaged in their skulls to define genotype- and age-related changes. Hippocampal, cerebellar, and brain volumes and corpus callosum length were quantified in 40-, 100-, 365-, and 630-day-old mice. Measurements taken at age 100 days, before Abeta deposition, revealed a 12.3% reduction of hippocampus volume in Tg mice compared with WT controls. This reduction persisted without progression to age 21 mos. A significant 18% increase in hippocampal volume occurred between 40 and 630 days in WT mice, and no corresponding significant increase occurred in Tg mice. Cavalieri volume estimates of hippocampal subfields from 100-day-old Tg mice further localized a 28% volume deficit in the dentate gyrus. In addition, corpus callosum length was reduced by approximately 25% in Tg mice at all ages analyzed. In summary, reduced hippocampal volume and corpus callosum length can be detected by MRM before Abeta deposition. We conclude that overexpression of APP and amyloid may initiate pathologic changes before the appearance of plaques, suggesting novel targets for the treatment of Alzheimer's disease and further reinforcing the need for early diagnosis and treatment.
高分辨率磁共振显微镜(MRM)被用于确定阿尔茨海默病小鼠模型中脑区的体积变化。这些转基因(Tg)小鼠在血小板衍生生长因子启动子的控制下过表达人类突变淀粉样前体蛋白(APP)V717F(PDAPP小鼠),杂合子在8 - 10个月后皮质和海马β淀粉样蛋白(Aβ)沉积增加。我们使用MRM获取在颅骨内成像的小鼠脑的三维体积数据,以确定与基因型和年龄相关的变化。对40日龄、100日龄、365日龄和630日龄的小鼠进行海马、小脑、脑体积和胼胝体长度的定量分析。在100日龄(Aβ沉积之前)进行的测量显示Tg小鼠的海马体积比野生型(WT)对照减少了12.3%。这种减少持续存在,到21个月龄时没有进一步发展。WT小鼠在40至630天之间海马体积显著增加了18%,而Tg小鼠没有相应的显著增加。对100日龄Tg小鼠海马亚区的 Cavalieri 体积估计进一步定位了齿状回中28%的体积缺陷。此外,在所有分析的年龄中,Tg小鼠的胼胝体长度减少了约25%。总之,在Aβ沉积之前,通过MRM可以检测到海马体积和胼胝体长度的减少。我们得出结论,APP和淀粉样蛋白的过表达可能在斑块出现之前就引发病理变化,这为阿尔茨海默病的治疗提出了新的靶点,并进一步强化了早期诊断和治疗的必要性。